| Literature DB >> 26586336 |
Seong-Lan Yu1, Dong Chul Lee2, Hyun Ahm Sohn2, Soo Young Lee3, Hyo Sung Jeon4, Joon H Lee5, Chang Gyo Park1, Hoi Young Lee1, Young Il Yeom2, Ji Woong Son3, Yoo Sang Yoon6, Jaeku Kang1.
Abstract
MicroRNAs (miRNAs) are recognized as crucial posttranscriptional regulators of gene expression, and play critical roles as oncogenes or tumor suppressors in various cancers. Here, we show that miR-196b is upregulated in mesenchymal-like-state non-small cell lung cancer (NSCLC) cells and lung cancer tissues. Moreover, miR-196b upregulation stimulates cell invasion and a change in cell morphology to a spindle shape via loss of cell-to-cell contacts. We identified homeobox A9 (HOXA9) as a target gene of miR-196b by using public databases such as TargetScan, miRDB, and microRNA.org. HOXA9 expression is inversely correlated with miR-196b levels in clinical NSCLC samples as compared to that in corresponding control samples, and with the migration and invasion of NSCLC cells. Ectopic expression of HOXA9 resulted in a suppression of miR-196b-induced cell invasion, and HOXA9 reexpression increased E-cadherin expression. Furthermore, HOXA9 potently attenuated the expression of snail family zinc finger 2 (SNAI2/SLUG) and matrix metallopeptidase 9 (MMP9) by controlling the binding of nuclear factor-kappa B to the promoter of SLUG and MMP9 genes, respectively. Therefore, we suggest that HOXA9 plays a central role in controlling the aggressive behavior of lung cancer cells and that miR-196b can serve as a potential target for developing anticancer agents.Entities:
Keywords: EMT; HOXA9; NF-κB; NSCLC; miR-196b
Mesh:
Substances:
Year: 2015 PMID: 26586336 DOI: 10.1002/mc.22439
Source DB: PubMed Journal: Mol Carcinog ISSN: 0899-1987 Impact factor: 4.784